CARLSMED, INC.
For the period ended Mar 31, 2026. Filed May 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 5, 2026
CARL$14.52-5.2%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
(in thousands)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Supplemental Disclosure of Noncash Investing and Financing Activities: | ||
| Vesting of early exercised common stock options | $10 | $10 |
| Unpaid deferred offering and issuance costs | $— | $1,124 |
| Capitalized internal use software included in accounts payable and accrued liabilities | $125 | $35 |
| Cash, Cash Equivalents, and Restricted Cash Information: | ||
| Cash and cash equivalents, beginning of period | $85,793 | $40,125 |
| Restricted cash, beginning of period | 100 | 100 |
| Cash, cash equivalents, and restricted cash, beginning of period | 85,893 | 40,225 |
| Cash and cash equivalents, end of period | 73,016 | 43,432 |
| Restricted cash, end of period | 100 | 100 |
| Cash, cash equivalents, and restricted cash, end of period | $73,116 | $43,532 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.